BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Saito K, Moriyasu F, Sugimoto K, Nishio R, Saguchi T, Nagao T, Taira J, Akata S, Tokuuye K. Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule. World J Gastroenterol 2011; 17(30): 3503-3509 [PMID: 21941417 DOI: 10.3748/wjg.v17.i30.3503]
URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3503.htm
Number Citing Articles
1
Yasuaki Takeyama, Naoaki Tsuchiya, Hideo Kunimoto, Atsushi Fukunaga, Kunitoshi Sakurai, Genryu Hirano, Keiji Yokoyama, Daisuke Morihara, Akira Anan, Makoto Irie, Satoshi Shakado, Tetsuro Sohda, Shotaro Sakisaka. Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosisHepatology Research 2015; 45(10): E108 doi: 10.1111/hepr.12470
2
Kazuhiro Saito, Joseph Ledsam, Steven Sourbron, Jun Otaka, Yoichi Araki, Soichi Akata, Koichi Tokuuye. Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocolJournal of Magnetic Resonance Imaging 2013; 37(5): 1109 doi: 10.1002/jmri.23907
3
Emina Talakic, Jürgen Steiner, Peter Kalmar, Andre Lutfi, Franz Quehenberger, Ursula Reiter, Michael Fuchsjäger, Helmut Schöllnast. Gd-EOB-DTPA enhanced MRI of the liver: Correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFREuropean Journal of Radiology 2014; 83(4): 607 doi: 10.1016/j.ejrad.2013.12.010
4
Maliheh Safavi, Reyhaneh Sabourian, Mohammad Abdollahi. The development of biomarkers to reduce attrition rate in drug discovery focused on oncology and central nervous systemExpert Opinion on Drug Discovery 2016; 11(10): 939 doi: 10.1080/17460441.2016.1217196
5
Ming Yang, Yue Zhang, Wenlu Zhao, Wen Cheng, Han Wang, Shengren Guo. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRIBMC Medical Imaging 2020; 20(1) doi: 10.1186/s12880-020-00519-7
6
Hee Yeon Kim, Jong Young Choi, Chung-Hwa Park, Myeong Jun Song, Do Seon Song, Chang Wook Kim, Si Hyun Bae, Seung Kew Yoon, Young Joon Lee, Sung Eun Rha. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosisJournal of Gastroenterology 2013; 48(10): 1180 doi: 10.1007/s00535-012-0740-7
7
Paola Erra, Marta Puglia, Alfonso Ragozzino, Simone Maurea, Raffaele Liuzzi, Giuseppe Sabino, Luigi Barbuto, Alberto Cuocolo, Massimo Imbriaco. Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic reviewLa radiologia medica 2015; 120(11): 1002 doi: 10.1007/s11547-015-0539-8
8
Alexander Kagen, Kathryn Fowler, Claude B Sirlin. Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRIHepatic Oncology 2014; 1(1): 95 doi: 10.2217/hep.13.11
9
Jie Chen, Mingpeng Wu, Rongbo Liu, Siyi Li, Ronghui Gao, Bin Song, Tian-wu Chen. Preoperative Evaluation of the Histological Grade of Hepatocellular Carcinoma with Diffusion-Weighted Imaging: A Meta-AnalysisPLOS ONE 2015; 10(2): e0117661 doi: 10.1371/journal.pone.0117661
10
Dan Wang, Ming-Liang Wang, Yue-Hua Li. Quantitative MRI study of the permeability of peritumoral brain edema in lung cancer patients with brain metastasesBrain Research 2017; 1669: 126 doi: 10.1016/j.brainres.2017.06.016
11
Stephanie Channual, Anokh Pahwa, David S. Lu, Steven S. Raman. Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imagingAbdominal Radiology 2016; 41(9): 1825 doi: 10.1007/s00261-016-0767-y